BlueRiver Acquisition in an 8-K said the shareholders meeting to cosider a deadline extension has been postponed from today until Aug. 2 at 4 p.m. Eastern. As a fresult, the redemption deadline is now July 31.
The SPAC wants to move its termination deadline to Feb. 2, 2024.
Earlier this week, the SPAC announced a merger deal with Spinal Stabilization Technologies and a non-redemption agreement covering 200,000 shares.
The target is a medical device company focused on developing and then commercializing a proprietary lumbar implant for nucleus pulposus replacement to alleviate certain types of lower back pain.
The combined company would have an estimated post-transaction enterprise value of approximately $302 million. That figure assumes a proposed $40 million PIPE and 100% redemptions by BlueRiver shareholders, the SPAC said at deal announcement Monday. Read more.
